×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| Jupiter Life Line Hospitals Li | 2908.23 | 432.94 | 2779.42 | 6.6 | 9,352 | 48.6 |
| SHILPA MEDICARE LTD. | 1102.23 | 206.97 | 924.33 | 2.12 | 8230 | 64.0 |
| STRIDES PHARMA SCIENCE LIMITED | 5003.74 | 133.47 | 4986.16 | 1.45 | 8120 | 21.6 |
Jupiter Life Line Hospitals Limited, with Security Code 543980, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 207.9 | 227.1 | 230.4 | 245.3 | 239.4 | 273.1 | 269.1 | 273.9 | 277.9 |
| Expenses | 156.7 | 168.3 | 173.3 | 188.9 | 183.7 | 203.7 | 201.7 | 201.6 | 210.4 |
| Operating Profit | 51.1 | 58.8 | 57.1 | 56.4 | 55.7 | 69.4 | 67.4 | 72.3 | 67.5 |
| OPM % | 24.6% | 25.89% | 24.76% | 22.98% | 23.26% | 25.43% | 25.06% | 26.39% | 24.3% |
| Other Income | 5.4 | 5.4 | 7.8 | 11.0 | 8.2 | 9.3 | 8.1 | 7.0 | 12.9 |
| Interest | 8.2 | 8.5 | 1.0 | 0.9 | 0.9 | 1.0 | 2.7 | 4.0 | 3.0 |
| Depreciation | 7.8 | 7.6 | 7.7 | 7.5 | 8.0 | 10.4 | 10.6 | 13.4 | 16.7 |
| Profit before tax | 42.0 | 48.8 | 56.3 | 56.7 | 55.0 | 67.3 | 62.3 | 61.9 | 60.8 |
| Tax % | -25% | -24.8% | -24.8% | -26.9% | -26.1% | -25.3% | -20.8% | -28% | 28.7% |
| Net Profit | 30.4 | 36.1 | 42.2 | 43.1 | 40.7 | 50.3 | 49.3 | 44.4 | 43.3 |
| EPS in Rs | 5.76 | 6.18 | 6.48 | 6.47 | 6.2 | 7.67 | 7.52 | 0 | 6.6 |
| Metrics | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Sales | 243.2 | 263.2 | 272.6 | 290.5 | 287.1 | 322.6 | 320.6 | 326.7 |
| Expenses | 190.2 | 202.1 | 210.8 | 228.2 | 223.3 | 247.6 | 245.6 | 248.4 |
| Operating Profit | 53.0 | 61.0 | 61.9 | 62.3 | 63.9 | 75.0 | 75.0 | 78.3 |
| OPM % | 21.79% | 23.19% | 22.69% | 21.44% | 22.24% | 23.25% | 23.39% | 23.97% |
| Other Income | 3.6 | 3.2 | 7.9 | 11.2 | 8.4 | 9.4 | 8.3 | 7.0 |
| Interest | 12.2 | 12.2 | 1.0 | 0.9 | 1.1 | 1.1 | 2.8 | 5.6 |
| Depreciation | 10.7 | 10.6 | 10.7 | 10.4 | 11.0 | 14.4 | 14.0 | 17.6 |
| Profit before tax | 35.1 | 42.1 | 58.2 | 59.9 | 60.1 | 68.9 | 66.6 | 62.2 |
| Tax % | 59.9% | -18.6% | -24.8% | -27.2% | 25.8% | 25.2% | 21.1% | -27.7% |
| Net Profit | 54.0 | 33.7 | 43.7 | 45.3 | 44.6 | 51.5 | 52.5 | 44.9 |
| EPS in Rs | 9.93 | 5.67 | 6.56 | 6.49 | 6.8 | 7.86 | 8.01 | 0 |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 18% |
| 3 Years: | 17% |
| TTM: | 16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 44% |
| 3 Years: | 30% |
| TTM: | 22% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 26% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 22% |
| 3 Years: | 20% |
| TTM: | 18% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 44% |
| 3 Years: | 56% |
| TTM: | 9% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 0% |
| 5 Years: | 0% |
| 3 Years: | 0% |
| 1 Year: | 26% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|